MacroGenics, Inc. (MGNX)
NASDAQ·Healthcare·Biotechnology
$3.03
-0.82%
Mkt Cap $193.86M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $34.59M | $41.23M | +19.19% | -$0.42 | -$0.22 | +47.62% | — | — |
| Q4 2025 Nov 12, 2025 | $27.81M | $72.84M | +161.94% | -$0.48 | $0.27 | +156.25% | — | — |
| Q3 2025 Aug 14, 2025 | $24.41M | $22.24M | -8.89% | -$0.59 | -$0.57 | +3.39% | — | — |
| Q2 2025 May 13, 2025 | $11.77M | $13.19M | +12.11% | -$0.61 | -$0.65 | -6.56% | — | — |
| Q1 2025 Mar 20, 2025 | $34.17M | $17.73M | -48.12% | -$0.23 | -$0.25 | -8.70% | — | — |
| Q4 2024 Nov 5, 2024 | $32.69M | $110.71M | +238.67% | $0.21 | $0.90 | +328.57% | — | — |
| Q3 2024 Aug 6, 2024 | $18.22M | $10.80M | -40.74% | -$0.47 | -$0.89 | -89.36% | — | — |
| Q2 2024 May 9, 2024 | $14.86M | $9.10M | -38.74% | -$0.67 | -$0.84 | -25.37% | — | — |
| Q1 2024 Mar 7, 2024 | $32.63M | $10.72M | -67.15% | -$0.26 | -$0.75 | -188.46% | — | — |
| Q4 2023 Nov 6, 2023 | $34.15M | $10.40M | -69.55% | -$0.11 | -$0.52 | -392.89% | — | — |
| Q3 2023 Aug 9, 2023 | $29.74M | $13.14M | -55.83% | -$0.52 | -$0.36 | +30.77% | — | — |
| Q2 2023 May 9, 2023 | $94.31M | $24.21M | -74.33% | $1.07 | -$0.61 | -157.01% | — | — |
| Q1 2023 Mar 15, 2023 | $58.78M | $71.18M | +21.09% | $0.10 | $0.21 | +110.00% | — | — |
| Q4 2022 Nov 3, 2022 | $29.28M | $41.73M | +42.52% | -$0.49 | -$0.40 | +18.37% | — | — |
| Q3 2022 Aug 8, 2022 | $14.16M | $26.01M | +83.64% | -$0.97 | -$0.67 | +30.93% | — | — |
| Q2 2022 May 3, 2022 | $7.94M | $10.67M | +34.38% | -$0.84 | -$1.08 | -28.57% | — | — |
| Q1 2022 Feb 24, 2022 | $22.23M | $13.62M | -38.71% | -$0.83 | -$0.95 | -14.46% | — | — |
| Q4 2021 Nov 2, 2021 | $37.22M | $15.58M | -58.15% | -$0.63 | -$0.86 | -36.51% | — | — |
| Q3 2021 Jul 29, 2021 | $26.85M | $30.37M | +13.13% | -$0.28 | -$0.66 | -135.71% | — | — |
| Q2 2021 Apr 29, 2021 | $27.95M | $16.07M | -42.50% | -$0.53 | -$0.90 | -69.81% | — | — |